Lilium davidii extract alleviates p‑chlorophenylalanine‑induced insomnia in rats through modification of the hypothalamic-related neurotransmitters, melatonin and homeostasis of the hypothalamic-pituitary-adrenal axis. (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Lilium davidii extract alleviates p‑chlorophenylalanine‑induced insomnia in rats through modification of the hypothalamic-related neurotransmitters, melatonin and homeostasis of the hypothalamic-pituitary-adrenal axis. (1st January 2020)
- Main Title:
- Lilium davidii extract alleviates p‑chlorophenylalanine‑induced insomnia in rats through modification of the hypothalamic-related neurotransmitters, melatonin and homeostasis of the hypothalamic-pituitary-adrenal axis
- Authors:
- Si, Yanpo
Wang, Lili
Lan, Jinxu
Li, Hanwei
Guo, Tao
Chen, Xiaohui
Dong, Chunhong
Ouyang, Zhen
Chen, Sui-qing - Abstract:
- Abstract: Context: Lilium davidii var. unicolour Cotton ( Lilium genus, Liliaceae) is an edible plant and a herb used in China to alleviate insomnia. Objective: To investigate the alleviating insomnia mechanism of L. davidii (LD). Materials and methods: Wistar rats were intraperitoneally injected with p -chlorophenylalanine (PCPA) to establish an insomnia model. Rats were divided into six groups ( n = 8): Control, PCPA, Estazolam (0.5 mg/kg), LD extract in low, medium and high doses (185.22, 370.44, 740.88 mg/kg). Serum hormone levels of the HPA axis, levels of 5-HT, NE and MT, and the expression of GABAA and 5-HT1A receptors in hypothalamus were determined. Moreover, behavioural and pathological changes in the hypothalamus were evaluated. Results: After LD administration, body weight and brain coefficient increased by 2.74% and 8.22%, respectively, and the adrenal coefficient decreased by 25%, compared with PCPA group. Elevation of the serum hypothalamic-pituitary-adrenal (HPA) axis hormone CRH (11.24 ± 3.16 ng/mL), ACTH (565.87 ± 103.44 pg/mL) and CORT (44.28 ± 8.73 ng/mL) in the PCPA group was reversed after LD treatment. Furthermore, abnormal excitatory behaviour [5 min movement distance (2096.34 ± 259.51 cm), central exercise time (5.28 ± 1.08 s)] of insomnia rats in the PCPA group was also relieved. LD extract increased 5-HT and MT levels, reduced NE level in the hypothalamus, and upregulated the expression of GABAA R and 5-HT1A. Moreover, LD extract may improve theAbstract: Context: Lilium davidii var. unicolour Cotton ( Lilium genus, Liliaceae) is an edible plant and a herb used in China to alleviate insomnia. Objective: To investigate the alleviating insomnia mechanism of L. davidii (LD). Materials and methods: Wistar rats were intraperitoneally injected with p -chlorophenylalanine (PCPA) to establish an insomnia model. Rats were divided into six groups ( n = 8): Control, PCPA, Estazolam (0.5 mg/kg), LD extract in low, medium and high doses (185.22, 370.44, 740.88 mg/kg). Serum hormone levels of the HPA axis, levels of 5-HT, NE and MT, and the expression of GABAA and 5-HT1A receptors in hypothalamus were determined. Moreover, behavioural and pathological changes in the hypothalamus were evaluated. Results: After LD administration, body weight and brain coefficient increased by 2.74% and 8.22%, respectively, and the adrenal coefficient decreased by 25%, compared with PCPA group. Elevation of the serum hypothalamic-pituitary-adrenal (HPA) axis hormone CRH (11.24 ± 3.16 ng/mL), ACTH (565.87 ± 103.44 pg/mL) and CORT (44.28 ± 8.73 ng/mL) in the PCPA group was reversed after LD treatment. Furthermore, abnormal excitatory behaviour [5 min movement distance (2096.34 ± 259.51 cm), central exercise time (5.28 ± 1.08 s)] of insomnia rats in the PCPA group was also relieved. LD extract increased 5-HT and MT levels, reduced NE level in the hypothalamus, and upregulated the expression of GABAA R and 5-HT1A. Moreover, LD extract may improve the pathology of neurons in the hypothalamus. Conclusions: LD can be considered to develop health-care food or novel drugs to cope with the increasing number of insomniacs. … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 58:Number 1(2020)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 58:Number 1(2020)
- Issue Display:
- Volume 58, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 58
- Issue:
- 1
- Issue Sort Value:
- 2020-0058-0001-0000
- Page Start:
- 915
- Page End:
- 924
- Publication Date:
- 2020-01-01
- Subjects:
- Hypothalamus -- serotonin -- γ-aminobutyric acid -- melatonin
Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13880209.2020.1812674 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22163.xml